- Home
- SUIG vs MREO Comparison
SUIG vs MREO Comparison
Compare SUIG & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUIG
- MREO
- Stock Information
- Founded
- SUIG 2006
- MREO 2015
- Country
- SUIG United States
- MREO United Kingdom
- Employees
- SUIG N/A
- MREO N/A
- Industry
- SUIG Finance Companies
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- SUIG Finance
- MREO Health Care
- Exchange
- SUIG Nasdaq
- MREO Nasdaq
- Market Cap
- SUIG 321.6M
- MREO 326.1M
- IPO Year
- SUIG N/A
- MREO N/A
- Fundamental
- Price
- SUIG $4.27
- MREO $1.97
- Analyst Decision
- SUIG
- MREO Strong Buy
- Analyst Count
- SUIG 0
- MREO 5
- Target Price
- SUIG N/A
- MREO $7.40
- AVG Volume (30 Days)
- SUIG 2.3M
- MREO 1.2M
- Earning Date
- SUIG 11-11-2025
- MREO 11-11-2025
- Dividend Yield
- SUIG N/A
- MREO N/A
- EPS Growth
- SUIG 619.34
- MREO N/A
- EPS
- SUIG 0.24
- MREO N/A
- Revenue
- SUIG $3,305,884.00
- MREO $500,000.00
- Revenue This Year
- SUIG N/A
- MREO N/A
- Revenue Next Year
- SUIG N/A
- MREO $72.16
- P/E Ratio
- SUIG $18.93
- MREO N/A
- Revenue Growth
- SUIG 1.77
- MREO N/A
- 52 Week Low
- SUIG $1.13
- MREO $1.47
- 52 Week High
- SUIG $8.66
- MREO $4.72
- Technical
- Relative Strength Index (RSI)
- SUIG N/A
- MREO 57.79
- Support Level
- SUIG N/A
- MREO $1.94
- Resistance Level
- SUIG N/A
- MREO $2.12
- Average True Range (ATR)
- SUIG 0.00
- MREO 0.11
- MACD
- SUIG 0.00
- MREO 0.02
- Stochastic Oscillator
- SUIG 0.00
- MREO 62.65
About SUIG Sui Group Holdings Limited Common Stock
Sui Group Holdings Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).